Skip to main content
Caplight Logo









Telepatia

Telepatia

Private
São PauloHealthcare & Life Scienceshttps://www.telepatia.ai/pt-br

Last Round

Series A

Jun 17, 2026

Total Funding Raised

$42M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Telepatia is a healthtech company that provides an artificial intelligence-driven healthcare platform designed to assist medical professionals with clinical documentation, decision support, and system integration.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, NLP & Conversational AI, EHR & EMR, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

clinical AIAI scribemedical scribeclinical decision supportCDSSelectronic health recordEHRAI healthcare agentmedical AIclinical copilothealthtechworkflow automationvertical SaaSAI documentationconversational AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Telepatia Comparables

Compare Telepatia with similar companies based on industry and business-model similarity.

Telepatia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sofya
85%
Doutor-AI
78%
Freed
77%

Telepatia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 17, 2026
SeedOct 20, 2025

Key People

Founding team and executive leadership

Nicolas Abad

Co-Founder CEO

Founding Team

Herval Freire

CTO

Executive Team

Miguel de Arteaga

Building An AI Doctor Revenue, CFO Revenue

Executive Team

Telepatia Investors

Notable investors and investment history

Telepatia investors
InvestorRounds
Andreessen HorowitzSeries A
SV AngelSeries A, Seed
A.CapitalSeed
A* CapitalSeries A
Abstract VenturesSeed
Nido VenturesSeed
CanarySeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Hiring increased to 19 roles, 30% of headcount.

  • Jul 29, 2026

    Open roles increased to 17, 7x the trailing average.

Telepatia Filings

Explore SEC and related filing metadata, where available.

Telepatia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Telepatia's valuation, stock price, and market status.

Is Telepatia a public or private company?

Telepatia is a private company.

What is the current stock price of Telepatia?

Telepatia is a private company with no public stock price. No recent secondary market data is available.

How much is Telepatia worth (valuation)?

Valuation information for Telepatia is not publicly available.

Can I buy Telepatia stock?

Telepatia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Telepatia's last funding round?

Telepatia's most recent funding round was Series A on June 17, 2026.

Who are the main investors in Telepatia?

Key investors in Telepatia include Andreessen Horowitz, A.Capital.

Will Telepatia IPO soon?

No public IPO plans have been announced for Telepatia.

How can I track Telepatia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Telepatia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSão Paulo
Employee Range84
Year Founded2025
Last FundingJun 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?